Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions

NCT03920800 is registered in ClinicalTrials.gov with Catherine Vanpachterbeke as lead sponsor.

NCT NCT03920800
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03920800 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Preventing Invasive Cervical Cancer: The Importance of Expectant Management in Young Women With High-grade Pre-cancerous Lesions
Lead sponsor
Catherine Vanpachterbeke
Phase
Observational
Overall status
Completed
Start date
March 1, 2019
Completion date
November 20, 2019
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

high-grade squamous intraepithelial lesions